LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on hemostasis monitoring at the 44th Annual Oak Ridge Conference, April 19, 2012, in San Jose, CA. The data highlight T2 Bio’s new assay, T2Hemostasis, which monitors key coagulation, platelet and other hematologic factors directly in whole blood.
